Sugong Chen1, Emina H Huang. 1. Department of Surgery, University of Florida, 1600 SW Archer Road, Gainesville, FL, 32610, USA, Sugong.chen@surgery.ufl.edu.
Abstract
BACKGROUND: Colorectal cancer remains the most common gastrointestinal cancer. While screening combined with effective surgical treatment has reduced its mortality, we still do not have effective means to prevent recurrence nor to treat metastatic disease. What we know about cancer biology has gone through revolutionary changes in recent decades. The advent of the cancer stem cell theory has accelerated our understanding of the cancer cell. However, there is increasing evidence that cancer cells are influenced by their surrounding microenvironment. PURPOSE: This review divides the tumor microenvironment into four functional components-the stem cell niche, cancer stroma, immune cells, and vascular endothelia-and examines their individual and collective influence on the growth and metastasis of the colon cancer stem cell. The discussion will highlight the need to fully exploit the tumor microenvironment when designing future prognostic tools and therapies.
BACKGROUND:Colorectal cancer remains the most common gastrointestinal cancer. While screening combined with effective surgical treatment has reduced its mortality, we still do not have effective means to prevent recurrence nor to treat metastatic disease. What we know about cancer biology has gone through revolutionary changes in recent decades. The advent of the cancer stem cell theory has accelerated our understanding of the cancer cell. However, there is increasing evidence that cancer cells are influenced by their surrounding microenvironment. PURPOSE: This review divides the tumor microenvironment into four functional components-the stem cell niche, cancer stroma, immune cells, and vascular endothelia-and examines their individual and collective influence on the growth and metastasis of the colon cancer stem cell. The discussion will highlight the need to fully exploit the tumor microenvironment when designing future prognostic tools and therapies.
Authors: Sheldon R Mink; Surabhi Vashistha; Wenxuan Zhang; Amanda Hodge; David B Agus; Anjali Jain Journal: Mol Cancer Res Date: 2010-06-08 Impact factor: 5.852
Authors: Michael I Koukourakis; Alexandra Giatromanolaki; Adrian L Harris; Efthimios Sivridis Journal: Cancer Res Date: 2006-01-15 Impact factor: 12.701
Authors: Joseph E Carpentino; Mark J Hynes; Henry D Appelman; Tong Zheng; Dennis A Steindler; Edward W Scott; Emina H Huang Journal: Cancer Res Date: 2009-10-06 Impact factor: 12.701
Authors: Valery Adorno-Cruz; Golam Kibria; Xia Liu; Mary Doherty; Damian J Junk; Dongyin Guan; Chris Hubert; Monica Venere; Erin Mulkearns-Hubert; Maksim Sinyuk; Alvaro Alvarado; Arnold I Caplan; Jeremy Rich; Stanton L Gerson; Justin Lathia; Huiping Liu Journal: Cancer Res Date: 2015-01-20 Impact factor: 12.701